查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1326245

医疗保健领域人工智能 (AI) 的全球市场

Artificial Intelligence (AI) in Healthcare
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球医疗保健人工智能 (AI) 市场将达到 3089 亿美元

在 COVID-19 后不断变化的商业环境中，全球医疗保健人工智能 (AI) 市场预计 2022 年为 280 亿美元，预计到 2030 年和 2022 年将达到 3089 亿美元。预计将增长2030年至2030年年复合成长率为35%。软件是本报告分析的细分市场之一，预计复合年增长率为 36.6%，到分析期结束时将达到 1,595 亿美元。考虑到疫情后持续的复苏，硬件行业未来八年的年复合成长率被修正为34.4%。

美国市场预计增长84亿美元，中国年复合成长率33.3%

预计到 2022 年，美国医疗保健人工智能 (AI) 市场价值将达到 84 亿美元。中国作为全球第二大经济体，预计到2030年市场规模将达到498亿美元，2022-2030年分析期间年复合成长率为33.3%。其他值得注意的地域市场包括日本和加拿大，预计从 2022 年到 2030 年，这两个市场将分别增长 30.8% 和 28.5%。在欧洲，德国预计年复合成长率为 21.6%。

受访企业示例

  • Amazon Web Services（Aws）
  • Enlitic Inc.
  • General Electric Company
  • General Vision
  • Google
  • IBM Corporation
  • iCarbonX
  • Intel Corporation
  • Johnson & Johnson Services
  • Koninklijke Philips
  • Medtronic
  • Micron Technology
  • Microsoft Corporation
  • Next IT Corp.
  • Nvidia Corporation
  • Siemens Healthineers（A Strategic Unit Of Siemens Group）
  • Welltok Inc.

目录

第1章调查方法

第2章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和促进因素
  • 全球市场预测

第3章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 意大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第4章竞争

简介目录
Product Code: MCP21181

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Artificial Intelligence (AI) in Healthcare Market to Reach $308.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Artificial Intelligence (AI) in Healthcare estimated at US$28 Billion in the year 2022, is projected to reach a revised size of US$308.9 Billion by 2030, growing at aCAGR of 35% over the period 2022-2030. Software, one of the segments analyzed in the report, is projected to record 36.6% CAGR and reach US$159.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Hardware segment is readjusted to a revised 34.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $8.4 Billion, While China is Forecast to Grow at 33.3% CAGR

The Artificial Intelligence (AI) in Healthcare market in the U.S. is estimated at US$8.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$49.8 Billion by the year 2030 trailing a CAGR of 33.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 30.8% and 28.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 21.6% CAGR.

Select Competitors (Total 222 Featured) -

  • Amazon Web Services (Aws)
  • Enlitic Inc.
  • General Electric Company
  • General Vision
  • Google
  • IBM Corporation
  • iCarbonX
  • Intel Corporation
  • Johnson & Johnson Services
  • Koninklijke Philips
  • Medtronic
  • Micron Technology
  • Microsoft Corporation
  • Next IT Corp.
  • Nvidia Corporation
  • Siemens Healthineers (A Strategic Unit Of Siemens Group)
  • Welltok Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Artificial Intelligence (AI) in Healthcare - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Healthcare Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Healthcare Payers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Hospitals & Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Pharmaceuticals & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Machine Learning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Machine Learning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Natural Language Processing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for Natural Language Processing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Context-Aware Computing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 22: World 8-Year Perspective for Context-Aware Computing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Computer Vision by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World 8-Year Perspective for Computer Vision by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 25: World Artificial Intelligence (AI) in Healthcare Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Connected Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World 8-Year Perspective for Connected Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Fraud Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 31: World 8-Year Perspective for Fraud Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: World 8-Year Perspective for Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Virtual Assistants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 35: World 8-Year Perspective for Virtual Assistants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Dosage Error Reduction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 37: World 8-Year Perspective for Dosage Error Reduction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 39: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 41: World 8-Year Perspective for Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 42: World Recent Past, Current & Future Analysis for Robot-Assisted Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 43: World 8-Year Perspective for Robot-Assisted Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2023 & 2030
    • TABLE 46: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 47: USA 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2023 & 2030
    • TABLE 48: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 49: USA 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2023 & 2030
  • CANADA
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Canada 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2023 & 2030
    • TABLE 54: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Canada 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2023 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2023 & 2030
    • TABLE 58: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 59: Canada 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2023 & 2030
  • JAPAN
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Japan 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2023 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2023 & 2030
    • TABLE 64: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Japan 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2023 & 2030
    • TABLE 66: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Japan 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2023 & 2030
  • CHINA
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: China 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2023 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 71: China 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2023 & 2030
    • TABLE 72: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 73: China 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2023 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2023 & 2030
  • EUROPE
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 77: Europe 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Europe 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2023 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2023 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Europe 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2023 & 2030
    • TABLE 84: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Europe 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2023 & 2030
  • FRANCE
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: France 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2023 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 89: France 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2023 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 91: France 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2023 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: France 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2023 & 2030
  • GERMANY
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Germany 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2023 & 2030
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Germany 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2023 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Germany 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2023 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 101: Germany 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2023 & 2030
  • ITALY
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 103: Italy 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2023 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Italy 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2023 & 2030
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 107: Italy 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2023 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 109: Italy 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2023 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: UK 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2023 & 2030
    • TABLE 112: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 113: UK 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2023 & 2030
    • TABLE 114: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 115: UK 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2023 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: UK 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2023 & 2030
    • TABLE 120: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 121: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2023 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2023 & 2030
    • TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 125: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2023 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2023 & 2030
    • TABLE 130: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 131: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2023 & 2030
    • TABLE 132: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 133: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2023 & 2030
    • TABLE 136: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 137: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2023 & 2030
    • TABLE 138: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 139: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2023 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2023 & 2030

IV. COMPETITION